Traditional brick and mortar clinical trials require patients to visit the nearest clinical site for their treatments and follow-up appointments, creating a considerable travel burden. In addition, such trials carry an increased safety risk for patients, who can develop potentially harmful complications that go unnoticed between site visits. To reduce barriers for patient participation in clinical trials, clinicians and scientists now develop methods for remote patient health assessments that enable patient-first, decentralized clinical trial design.
Download this guide from Medable to learn how to decentralize clinical trials, improve clinician oversight between site visits, and increase patient safety.